Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01233375
What this trial is testing

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Clovis Oncology, Inc. 19
Very early researchStudy completedNCT02153450
What this trial is testing

Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
Case Comprehensive Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT02132468
What this trial is testing

A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers

Who this might be right for
Neuroendocrine Tumors
Mateon Therapeutics 18
Large-scale testing (Phase 3)Study completedNCT00425360
What this trial is testing

Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Royal Liverpool University Hospital 1,110
Large-scale testing (Phase 3)Study completedNCT00003216
What this trial is testing

Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Radiation Therapy Oncology Group 518
Not applicableLooking for participantsNCT07532590
What this trial is testing

Patients With Pancreatic Tumor: Use of an App to Monitor Progress in a Simple and Intuitive Way by Periodically Completing Targeted Questionnaires and Providing Educational and Informational Content (PancreasPlus).

Who this might be right for
Ductal Adenocarcinoma of PancreasPancreatectomyCaregiver+3 more
Casa di Cura Dott. Pederzoli 185
Testing effectiveness (Phase 2)WithdrawnNCT06518538
What this trial is testing

Evaluate Efficacy of Devimistat in Combination With mFFX in 2nd Line Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Stage IV
Cornerstone Pharmaceuticals
Not applicableLooking for participantsNCT06988150
What this trial is testing

Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic AdenocarcinomaWeight Loss
Cedars-Sinai Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT00003018
What this trial is testing

S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
SWOG Cancer Research Network 54
Testing effectiveness (Phase 2)Study completedNCT02468076
What this trial is testing

Radiofrequency Ablation for Biliopancreatic Malignancy

Who this might be right for
Pancreas CancerCholangiocarcinomaObstructive Jaundice
Universitaire Ziekenhuizen KU Leuven 18
Early research (Phase 1)Study completedNCT01643499
What this trial is testing

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasAdenocarcinoma of the GallbladderAdenocarcinoma of Unknown Primary+37 more
University of Chicago 79
Very early researchLooking for participantsNCT07595237
What this trial is testing

A IIT Study of 177Lu-DOTA-SNA040

Who this might be right for
Advanced Solid Tumors (Such as Gastric Cancer)Advanced Solid Tumors (Such as Adenocarcinoma at the Gastroesophageal Junction)Advanced Solid Tumors (Such as Pancreatic Cancer)+1 more
SmartNuclide Biopharma 12
Not applicableStudy completedNCT05025371
What this trial is testing

The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreas Cancer, Duct Cell Adenocarcinoma
Iuliu Hatieganu University of Medicine and Pharmacy 312
Testing effectiveness (Phase 2)Ended earlyNCT03450018
What this trial is testing

SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
British Columbia Cancer Agency 6
Testing effectiveness (Phase 2)Looking for participantsNCT06914128
What this trial is testing

PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Who this might be right for
MTAP-deleted Solid Tumors
Bayer 450
Not applicableUnknownNCT04677244
What this trial is testing

Echo-endoscopy Biopsy Impact on the Circulating Tumor Cell Level

Who this might be right for
Cancer of Pancreas
Institut Paoli-Calmettes 42
Early research (Phase 1)Looking for participantsNCT06393400
What this trial is testing

CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)

Who this might be right for
Unresectable or Metastatic Advanced Pancreatic Ductal Adenocarcinoma
John Lenehan 20
Testing effectiveness (Phase 2)Study completedNCT00006467
What this trial is testing

Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 48
Early research (Phase 1)Active Not RecruitingNCT07021066
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors

Who this might be right for
Gastric AdenocarcinomaAdvanced Pancreatic Ductal AdenocarcinomaEsophageal Adenocarcinoma+2 more
SystImmune Inc. 160
Testing effectiveness (Phase 2)Ended earlyNCT01215578
What this trial is testing

Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors

Who this might be right for
Neuroendocrine TumorsPancreatic NeoplasmsAdvanced Disease+1 more
Assistance Publique - Hôpitaux de Paris 33
Next Page